ID KCRB_RAT Reviewed; 381 AA. AC P07335; A0JPK7; Q499P7; Q5PPJ5; Q6IRE0; Q6P139; DT 01-APR-1988, integrated into UniProtKB/Swiss-Prot. DT 09-JAN-2007, sequence version 2. DT 24-JAN-2024, entry version 181. DE RecName: Full=Creatine kinase B-type; DE EC=2.7.3.2; DE AltName: Full=B-CK; DE AltName: Full=Creatine kinase B chain; DE AltName: Full=Creatine phosphokinase M-type; DE Short=CPK-B; GN Name=Ckb; Synonyms=Ckbb; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3005113; DOI=10.1016/0378-1119(85)90321-x; RA Benfield P.A., Henderson L., Pearson M.L.; RT "Expression of a rat brain creatine kinase-beta-galactosidase fusion RT protein in Escherichia coli and derivation of the complete amino acid RT sequence of rat brain creatine kinase."; RL Gene 39:263-267(1985). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=2838389; DOI=10.1016/0378-1119(88)90527-6; RA Benfield P.A., Graf D., Korolkoff P.N., Hobson G., Pearson M.L.; RT "Isolation of four rat creatine kinase genes and identification of multiple RT potential promoter sequences within the rat brain creatine kinase promoter RT region."; RL Gene 63:227-243(1988). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA]. RC TISSUE=Uterus; RX PubMed=2284002; DOI=10.1210/mend-4-7-1000; RA Pentecost B.T., Mattheiss L., Dickerman H.W., Kumar S.A.; RT "Estrogen regulation of creatine kinase-B in the rat uterus."; RL Mol. Endocrinol. 4:1000-1010(1990). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain, Embryonic brain, Heart, and Prostate; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP PROTEIN SEQUENCE OF 33-43; 87-96; 108-130; 138-148; 157-172; 224-236; RP 253-265 AND 320-341, AND IDENTIFICATION BY MASS SPECTROMETRY. RC STRAIN=Sprague-Dawley; TISSUE=Hippocampus, and Spinal cord; RA Lubec G., Afjehi-Sadat L., Diao W., Chen W.-Q.; RL Submitted (APR-2007) to UniProtKB. RN [6] RP PHOSPHORYLATION. RX PubMed=6477506; DOI=10.1042/bj2220139; RA Mahadevan L.C., Whatley S.A., Leung T.K.C., Lim L.; RT "The brain isoform of a key ATP-regulating enzyme, creatine kinase, is a RT phosphoprotein."; RL Biochem. J. 222:139-144(1984). RN [7] RP TISSUE SPECIFICITY. RX PubMed=1939264; DOI=10.1016/s0021-9258(18)54587-7; RA Friedman D.L., Perryman M.B.; RT "Compartmentation of multiple forms of creatine kinase in the distal RT nephron of the rat kidney."; RL J. Biol. Chem. 266:22404-22410(1991). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-35 AND SER-309, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22673903; DOI=10.1038/ncomms1871; RA Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C., RA Olsen J.V.; RT "Quantitative maps of protein phosphorylation sites across 14 different rat RT organs and tissues."; RL Nat. Commun. 3:876-876(2012). CC -!- FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP CC and various phosphogens (e.g. creatine phosphate). Creatine kinase CC isoenzymes play a central role in energy transduction in tissues with CC large, fluctuating energy demands, such as skeletal muscle, heart, CC brain and spermatozoa. Acts as a key regulator of adaptive CC thermogenesis as part of the futile creatine cycle: localizes to the CC mitochondria of thermogenic fat cells and acts by mediating CC phosphorylation of creatine to initiate a futile cycle of creatine CC phosphorylation and dephosphorylation. During the futile creatine CC cycle, creatine and N-phosphocreatine are in a futile cycle, which CC dissipates the high energy charge of N-phosphocreatine as heat without CC performing any mechanical or chemical work. CC {ECO:0000250|UniProtKB:Q04447}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + creatine = ADP + H(+) + N-phosphocreatine; CC Xref=Rhea:RHEA:17157, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:57947, ChEBI:CHEBI:58092, ChEBI:CHEBI:456216; EC=2.7.3.2; CC Evidence={ECO:0000250|UniProtKB:Q04447, ECO:0000255|PROSITE- CC ProRule:PRU10029}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17158; CC Evidence={ECO:0000250|UniProtKB:Q04447}; CC -!- SUBUNIT: Dimer of identical or non-identical chains, which can be CC either B (brain type) or M (muscle type). With MM being the major form CC in skeletal muscle and myocardium, MB existing in myocardium, and BB CC existing in many tissues, especially brain. Interacts with SLC12A6 (via CC C-terminus); the interaction may be required for SLC12A6 potassium- CC chloride cotransport activity (By similarity). CC {ECO:0000250|UniProtKB:P12277}. CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:Q04447}. Mitochondrion CC {ECO:0000250|UniProtKB:Q04447}. Cell membrane CC {ECO:0000250|UniProtKB:P12277}. Note=Localizes to the mitochondria of CC thermogenic fat cells via the internal MTS-like signal (iMTS-L) region. CC {ECO:0000250|UniProtKB:Q04447}. CC -!- TISSUE SPECIFICITY: In the kidney localized primarily in the outer CC medulla in the thick ascending limb and distal convoluted tubule. CC {ECO:0000269|PubMed:1939264}. CC -!- DOMAIN: The internal MTS-like signal (iMTS-L) mediates targeting to CC mitochondria thermogenic fat cells. {ECO:0000250|UniProtKB:Q04447}. CC -!- SIMILARITY: Belongs to the ATP:guanido phosphotransferase family. CC {ECO:0000255|PROSITE-ProRule:PRU00842, ECO:0000255|PROSITE- CC ProRule:PRU00843}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH87656.1; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M14400; AAA40930.1; -; mRNA. DR EMBL; M18668; AAA40932.1; -; Genomic_DNA. DR EMBL; M57664; AAA40933.1; -; mRNA. DR EMBL; M57665; AAA40931.1; -; Genomic_DNA. DR EMBL; BC065307; AAH65307.2; -; mRNA. DR EMBL; BC070955; AAH70955.2; -; mRNA. DR EMBL; BC087656; AAH87656.1; ALT_INIT; mRNA. DR EMBL; BC099814; AAH99814.2; -; mRNA. DR EMBL; BC127477; AAI27478.2; -; mRNA. DR PIR; A23980; KIRTCB. DR RefSeq; NP_036661.3; NM_012529.3. DR AlphaFoldDB; P07335; -. DR SMR; P07335; -. DR BioGRID; 246448; 4. DR CORUM; P07335; -. DR IntAct; P07335; 3. DR MINT; P07335; -. DR STRING; 10116.ENSRNOP00000015122; -. DR ChEMBL; CHEMBL2176812; -. DR MoonProt; P07335; -. DR CarbonylDB; P07335; -. DR GlyGen; P07335; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P07335; -. DR PhosphoSitePlus; P07335; -. DR SwissPalm; P07335; -. DR jPOST; P07335; -. DR PaxDb; 10116-ENSRNOP00000015122; -. DR GeneID; 24264; -. DR KEGG; rno:24264; -. DR UCSC; RGD:2357; rat. DR AGR; RGD:2357; -. DR CTD; 1152; -. DR RGD; 2357; Ckb. DR VEuPathDB; HostDB:ENSRNOG00000010872; -. DR eggNOG; KOG3581; Eukaryota. DR HOGENOM; CLU_019868_4_2_1; -. DR InParanoid; P07335; -. DR OrthoDB; 35839at2759; -. DR PhylomeDB; P07335; -. DR TreeFam; TF314214; -. DR BRENDA; 2.7.3.2; 5301. DR Reactome; R-RNO-71288; Creatine metabolism. DR Reactome; R-RNO-9696264; RND3 GTPase cycle. DR PRO; PR:P07335; -. DR Proteomes; UP000002494; Chromosome 6. DR Bgee; ENSRNOG00000010872; Expressed in cerebellum and 20 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell. DR GO; GO:0030425; C:dendrite; IDA:RGD. DR GO; GO:0005739; C:mitochondrion; ISS:UniProtKB. DR GO; GO:0043025; C:neuronal cell body; IDA:RGD. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004111; F:creatine kinase activity; ISS:UniProtKB. DR GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD. DR GO; GO:0071391; P:cellular response to estrogen stimulus; IEP:RGD. DR GO; GO:1904568; P:cellular response to wortmannin; IEP:RGD. DR GO; GO:0021549; P:cerebellum development; IEP:RGD. DR GO; GO:0140651; P:futile creatine cycle; ISO:RGD. DR GO; GO:0030644; P:intracellular chloride ion homeostasis; IMP:RGD. DR GO; GO:0046314; P:phosphocreatine biosynthetic process; IBA:GO_Central. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR CDD; cd00716; creatine_kinase_like; 1. DR Gene3D; 1.10.135.10; ATP:guanido phosphotransferase, N-terminal domain; 1. DR Gene3D; 3.30.590.10; Glutamine synthetase/guanido kinase, catalytic domain; 1. DR InterPro; IPR000749; ATP-guanido_PTrfase. DR InterPro; IPR022415; ATP-guanido_PTrfase_AS. DR InterPro; IPR022414; ATP-guanido_PTrfase_cat. DR InterPro; IPR022413; ATP-guanido_PTrfase_N. DR InterPro; IPR036802; ATP-guanido_PTrfase_N_sf. DR InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom. DR PANTHER; PTHR11547; ARGININE OR CREATINE KINASE; 1. DR PANTHER; PTHR11547:SF23; CREATINE KINASE B-TYPE; 1. DR Pfam; PF00217; ATP-gua_Ptrans; 1. DR Pfam; PF02807; ATP-gua_PtransN; 1. DR SUPFAM; SSF55931; Glutamine synthetase/guanido kinase; 1. DR SUPFAM; SSF48034; Guanido kinase N-terminal domain; 1. DR PROSITE; PS00112; PHOSPHAGEN_KINASE; 1. DR PROSITE; PS51510; PHOSPHAGEN_KINASE_C; 1. DR PROSITE; PS51509; PHOSPHAGEN_KINASE_N; 1. DR World-2DPAGE; 0004:P07335; -. DR Genevisible; P07335; RN. PE 1: Evidence at protein level; KW ATP-binding; Cell membrane; Cytoplasm; Direct protein sequencing; Kinase; KW Membrane; Mitochondrion; Nitration; Nucleotide-binding; Phosphoprotein; KW Reference proteome; Transferase. FT CHAIN 1..381 FT /note="Creatine kinase B-type" FT /id="PRO_0000211970" FT DOMAIN 11..98 FT /note="Phosphagen kinase N-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00842" FT DOMAIN 125..367 FT /note="Phosphagen kinase C-terminal" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT REGION 96..122 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 130..138 FT /note="Internal MTS-like signal" FT /evidence="ECO:0000250|UniProtKB:Q04447" FT COMPBIAS 96..113 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 72 FT /ligand="creatine" FT /ligand_id="ChEBI:CHEBI:57947" FT /evidence="ECO:0000250|UniProtKB:P12277" FT BINDING 128..132 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 130 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 132 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 191 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 232 FT /ligand="creatine" FT /ligand_id="ChEBI:CHEBI:57947" FT /evidence="ECO:0000250|UniProtKB:P12277" FT BINDING 236 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 285 FT /ligand="creatine" FT /ligand_id="ChEBI:CHEBI:57947" FT /evidence="ECO:0000250|UniProtKB:P12277" FT BINDING 292 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 320..325 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 320 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT BINDING 335 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00843" FT MOD_RES 4 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P12277" FT MOD_RES 35 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 125 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q04447" FT MOD_RES 199 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P12277" FT MOD_RES 269 FT /note="3'-nitrotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q04447" FT MOD_RES 309 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:22673903" FT MOD_RES 322 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q04447" FT CONFLICT 18 FT /note="D -> A (in Ref. 3; AAA40931/AAA40933)" FT /evidence="ECO:0000305" FT CONFLICT 183..184 FT /note="EQ -> DE (in Ref. 1; AAA40930 and 2; AAA40932)" FT /evidence="ECO:0000305" FT CONFLICT 206 FT /note="G -> A (in Ref. 2; AAA40932)" FT /evidence="ECO:0000305" SQ SEQUENCE 381 AA; 42725 MW; A8C8A09F6FF1A4D1 CRC64; MPFSNSHNTQ KLRFPAEDEF PDLSSHNNHM AKVLTPELYA ELRAKCTPSG FTLDDAIQTG VDNPGHPYIM TVGAVAGDEE SYDVFKDLFD PIIEDRHGGY QPSDEHKTDL NPDNLQGGDD LDPNYVLSSR VRTGRSIRGF CLPPHCSRGE RRAIEKLAVE ALSSLDGDLS GRYYALKSMT EAEQQQLIDD HFLFDKPVSP LLLASGMARD WPDARGIWHN DNKTFLVWIN EEDHLRVISM QKGGNMKEVF TRFCTGLTQI ETLFKSKNYE FMWNPHLGYI LTCPSNLGTG LRAGVHIKLP HLGKHEKFSE VLKRLRLQKR GTGGVDTAAV GGVFDVSNAD RLGFSEVELV QMVVDGVKLL IEMEQRLEQG QPIDDLMPAQ K //